InvestorsHub Logo
Followers 163
Posts 12925
Boards Moderated 1
Alias Born 01/26/2016

Re: In for the long post# 255074

Wednesday, 12/11/2019 10:36:52 AM

Wednesday, December 11, 2019 10:36:52 AM

Post# of 702436
In for the long,

When I think about how NWBO and others have had to battle to try and get the process to favor improvement for some rather than just a set efficacy goal I get upset. As you may know, flipper44 and I both agreed that Immunocellular Therapeutics had a product that worked to help a subset of patients and yet the company did not get ICT-107 approved for that subset and instead folded. The cost to some patients and their families is simply crushing when a benefit can be found but one that does not help the majority of patients yet. The setback from failure to gain approval for those who would benefit is in terms of years which means help for some, which used in combo might help improve outcomes even more, is completely lost for their lifetimes. You and others in similar situations are why many of us chose to invest here. We have been looking for a cure and not just a 2 month benefit or even no benefit that big pharma can get away with by the size of their studies, other uses for already approved products and their influence. Praying you see the better day in cancer treatment ahead if us and many more "good days" ahead. Blessings and best wishes.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News